This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignees: Tohoku University, Nagoya University, Shionogi Company Limited. Active years: 2014-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Miyagi, JP (2022)
- Sendai, JP (2014 - 2024)
Company Filing History:
2 out of 1,058 
1 out of 371 
1 out of 1,001 
Years Active: 2014-2024
Title: Hirokazu Arimoto: Innovator in Autophagy Mechanisms
Introduction
Hirokazu Arimoto, based in Sendai, Japan, is an accomplished inventor with a notable portfolio of three patents. His work focuses primarily on innovative approaches to cellular degradation and autophagy, which play crucial roles in cellular health and disease management.
Latest Patents
Arimoto's latest patents demonstrate his commitment to advancing medical science. One of his significant inventions is a novel heterocyclic compound that induces degradation by autophagy of an intracellular molecule. This compound links a ligand that effectively binds to an intracellular molecule with a structure that promotes autophagy, ensuring that both components retain their activity. Another prominent patent focuses on a degradation agent utilizing the autophagic mechanism for damaged mitochondria. This invention comprises a compound capable of specifically targeting injured mitochondria and includes a substituent characterized by a general formula involving hydrogen atoms or similar structures.
Career Highlights
Hirokazu Arimoto has made remarkable contributions through his professional associations with esteemed institutions such as Tohoku University and the National University Corporation Nagoya University. His tenure at these prestigious organizations has significantly influenced the field of cellular biology and biotechnology.
Collaborations
Throughout his career, Arimoto has collaborated with notable colleagues, including Jun Lu and Yoshinori Yamano. Their collective expertise has contributed to advancements in understanding autophagic processes and their applications in therapeutic settings.
Conclusion
Hirokazu Arimoto stands out as a pivotal figure in the landscape of innovations related to cellular degradation and autophagy. His contributions through patents and collaborative efforts continue to inspire research and development in the biotechnology sector, potentially leading to new treatments for a variety of diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile